Latest Insider Transactions at Cerevel Therapeutics Holdings, Inc. (CERE)
This section provides a real-time view of insider transactions for Cerevel Therapeutics Holdings, Inc. (CERE). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Cerevel Therapeutics Holdings, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Cerevel Therapeutics Holdings, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 17
2021
|
Gabrielle Sulzberger |
BUY
Open market or private purchase
|
Direct |
21,084
+37.36%
|
$274,092
$13.06 P/Share
|
|
Jan 26
2021
|
Orly Mishan Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
38,450
+50.0%
|
$115,350
$3.5 P/Share
|
|
Jan 04
2021
|
Norbert G Riedel |
BUY
Exercise of conversion of derivative security
|
Direct |
14,270
+33.33%
|
-
|
|
Nov 09
2020
|
Christopher R Gordon |
BUY
Open market or private purchase
|
Indirect |
332,293
+0.55%
|
$3,322,930
$10.3 P/Share
|
|
Nov 09
2020
|
Adam Koppel |
BUY
Open market or private purchase
|
Indirect |
332,293
+0.55%
|
$3,322,930
$10.3 P/Share
|
|
Nov 09
2020
|
Bain Capital Investors LLC |
BUY
Open market or private purchase
|
Indirect |
332,293
+0.55%
|
$3,322,930
$10.3 P/Share
|
|
Oct 27
2020
|
Christopher R Gordon |
BUY
Open market or private purchase
|
Indirect |
10,000,000
+14.22%
|
$100,000,000
$10.0 P/Share
|
|
Oct 27
2020
|
Christopher R Gordon |
BUY
Other acquisition or disposition
|
Indirect |
49,961,943
+49.83%
|
-
|
|
Oct 27
2020
|
Adam Koppel |
BUY
Open market or private purchase
|
Indirect |
10,000,000
+14.22%
|
$100,000,000
$10.0 P/Share
|
|
Oct 27
2020
|
Adam Koppel |
BUY
Other acquisition or disposition
|
Indirect |
49,961,943
+49.83%
|
-
|
|
Oct 27
2020
|
Bain Capital Investors LLC |
BUY
Open market or private purchase
|
Indirect |
10,000,000
+14.22%
|
$100,000,000
$10.0 P/Share
|
|
Oct 27
2020
|
Pfizer Inc |
BUY
Open market or private purchase
|
Direct |
1,200,000
+4.2%
|
$12,000,000
$10.0 P/Share
|
|
Oct 27
2020
|
Perceptive Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
3,000,000
+48.72%
|
$30,000,000
$10.0 P/Share
|
|
Oct 21
2020
|
Perceptive Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
43,195
+21.54%
|
$431,950
$10.09 P/Share
|
|
Oct 20
2020
|
Perceptive Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
114,100
+50.0%
|
$1,141,000
$10.0 P/Share
|